ES524128A0 - Procedimiento para la fabricacion de nuevos derivados de la amino-3 quinuclidina - Google Patents

Procedimiento para la fabricacion de nuevos derivados de la amino-3 quinuclidina

Info

Publication number
ES524128A0
ES524128A0 ES524128A ES524128A ES524128A0 ES 524128 A0 ES524128 A0 ES 524128A0 ES 524128 A ES524128 A ES 524128A ES 524128 A ES524128 A ES 524128A ES 524128 A0 ES524128 A0 ES 524128A0
Authority
ES
Spain
Prior art keywords
quinuclidine
amino
procedure
manufacture
new derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES524128A
Other languages
English (en)
Other versions
ES8403897A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Publication of ES524128A0 publication Critical patent/ES524128A0/es
Publication of ES8403897A1 publication Critical patent/ES8403897A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES524128A 1982-07-02 1983-07-01 Procedimiento para la fabricacion de nuevos derivados de la amino-3 quinuclidina Expired ES8403897A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8211670A FR2529548A1 (fr) 1982-07-02 1982-07-02 Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique

Publications (2)

Publication Number Publication Date
ES524128A0 true ES524128A0 (es) 1984-04-16
ES8403897A1 ES8403897A1 (es) 1984-04-16

Family

ID=9275643

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524128A Expired ES8403897A1 (es) 1982-07-02 1983-07-01 Procedimiento para la fabricacion de nuevos derivados de la amino-3 quinuclidina

Country Status (9)

Country Link
US (1) US4657911A (es)
EP (1) EP0099789B1 (es)
JP (1) JPS5921684A (es)
AU (1) AU562210B2 (es)
CA (1) CA1265802A (es)
DE (1) DE3372769D1 (es)
ES (1) ES8403897A1 (es)
FR (1) FR2529548A1 (es)
ZA (1) ZA834704B (es)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
JPS5936675A (ja) * 1982-07-13 1984-02-28 サンド・アクチエンゲゼルシヤフト 二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
US5175173A (en) * 1983-12-22 1992-12-29 Sun Jung Hui Carboxamides useful as antiemetic or antipsychotic agents
US4593034A (en) * 1984-04-06 1986-06-03 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides
US4870181A (en) * 1985-02-04 1989-09-26 A. H. Robins Company, Incorporated Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2])octan-3-yl)aminobenzamides
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
GB8511988D0 (en) * 1985-05-11 1985-06-19 Beecham Group Plc Compounds
GB8520616D0 (en) * 1985-08-16 1985-09-25 Beecham Group Plc Compounds
GB8525844D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
US4722834A (en) * 1986-03-05 1988-02-02 A. H. Robins Company, Incorporated Method of using 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide-N-oxides to control emesis caused by anticancer drugs
US4717563A (en) * 1986-03-05 1988-01-05 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
DE3780276T2 (de) * 1986-12-16 1993-02-25 Robins Co Inc A H Angstloesende n-(1-azabicyclo(2.2.2)oct-3-yl)benzamide und -thiobenzamide.
US5246941A (en) 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
FR2610323B1 (fr) 1987-02-04 1989-06-23 Delalande Sa Enantiomeres de configuration absolue s de derives amide de l'amino-3 quinuclidine, leur procede de preparation et leur application en therapeutique
US5237066A (en) * 1987-02-04 1993-08-17 Delande S.A. Enantiomers of absolute configuration S of amide derivatives of 3-aminoquinuclidine, the process for preparing them and their application in therapy
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides
GB8720805D0 (en) * 1987-09-04 1987-10-14 Naylor R J 2-alkoxy-n-(1-azabicyclo(2 2 2)oct-3-yl)benzamides & thiobenzamides
EP0311724A1 (en) * 1987-10-16 1989-04-19 Synthelabo Anxiolytic-R-N-(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides
FR2625678B1 (fr) * 1988-01-13 1991-06-07 Delalande Sa Agents anorexigenes a base de n-(quinuclidin-3-yl)-benzamides ou thiobenzamides
US4863919A (en) * 1988-02-01 1989-09-05 A. H. Robins Company, Incorporated Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes
DE3878235T2 (de) * 1988-08-04 1993-06-03 Synthelabo Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.)oct-3-yl)benzamide und thiobenzamide.
WO1990005525A1 (en) * 1988-11-23 1990-05-31 Pfizer Inc. Quinuclidine derivatives as substance p antagonists
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds
US5290938A (en) * 1989-09-15 1994-03-01 Chiron Laboratories A.S. Preparation of S-(-)- and R-(+)-N-(quinuclidinyl-3)-amide
NO168529C (no) * 1989-09-15 1992-03-04 Chiron Lab As Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider.
US5070095A (en) * 1990-12-12 1991-12-03 A. H. Robins Company, Incorporated Substituted 4-(amidino)benzamides of 1-azabicyclo[2.2.2]octan-3- and -4-amine as gastric prokinetic, antiemetic, and anxiolytic agents
GB9027487D0 (en) * 1990-12-19 1991-02-06 Beecham Group Plc Pharmaceuticals
US5084460A (en) * 1990-12-24 1992-01-28 A. H. Robins Company, Incorporated Methods of therapeutic treatment with N-(3-ouinuclidinyl)-2-hydroxybenzamides and thiobenzamides
US5138060A (en) * 1991-01-03 1992-08-11 Pfizer Inc. Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines
US5236931A (en) * 1992-03-26 1993-08-17 A. H. Robins Company, Incorporated 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine and 3-quinuclidinol
US5273972A (en) * 1992-03-26 1993-12-28 A. H. Robins Company, Incorporated [(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates
FR2719842B1 (fr) * 1994-05-10 1996-06-07 Synthelabo Sels quaternaires de dérivés de 1-azabicyclo [2.2.2] octane, leur préparation et leur application en thérapeutique.
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
SE0000540D0 (sv) 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
JP2004506735A (ja) 2000-08-18 2004-03-04 ファルマシア・アンド・アップジョン・カンパニー 疾患治療用キヌクリジン置換アリール化合物
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2001282873A1 (en) 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
US6500840B2 (en) 2000-08-21 2002-12-31 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
WO2002015662A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
CA2455773A1 (en) * 2001-08-24 2003-03-06 Pharmacia & Upjohn Company Substituted-aryl 7-aza¬2.2.1|bicycloheptanes for the treatment of disease
US6852716B2 (en) 2002-02-15 2005-02-08 Pfizer Inc Substituted-aryl compounds for treatment of disease
BR0307874A (pt) * 2002-02-20 2004-12-28 Upjohn Co Atividade de compostos azabicìclicos com receptor de acetilcolina nicotìnica alfa7
WO2004013137A1 (en) 2002-08-01 2004-02-12 Pharmacia & Upjohn Company Llc 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
KR20060125812A (ko) * 2003-12-22 2006-12-06 아스트라제네카 아베 니코틴성 아세틸콜린 수용체 리간드
EP2083921A2 (en) 2006-09-04 2009-08-05 Neurosearch A/S Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
WO2008119710A1 (en) * 2007-03-30 2008-10-09 Neurosearch A/S Two-phase test method for characterizing the effect of a chemical compound on a test animal and maze for carrying out the method
DK2432467T3 (en) 2009-05-20 2018-04-16 Inst Nat Sante Rech Med SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS FOR USE IN TREATMENT OF VESTIBULAR DAMAGE LESSONS
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE331841B (es) * 1967-05-23 1971-01-18 Astra Ab
US3534053A (en) * 1967-05-24 1970-10-13 American Home Prod Quinuclidine derivatives
US3702324A (en) * 1970-06-24 1972-11-07 Stanford Research Inst 3,4,5-trimethoxybenzamides of substituted anilines and of alkylpiperidines
FR2183565B1 (es) * 1972-05-10 1975-12-26 Cerm Cent Europ Rech Mauvernay
CH614709A5 (es) * 1975-09-25 1979-12-14 Ciba Geigy Ag
NL7611713A (nl) * 1975-11-03 1977-05-05 Thomae Gmbh Dr K Werkwijze voor de bereiding van verbindingen en preparaten met waardevolle farmacologische eigen- schappen.
FR2329226A1 (fr) * 1975-11-03 1977-05-27 Ipa Ind Plastique Aquitain Porte-documents ou pochette
US4203989A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal diaryl-(1-azabicyclo(2.2.2)octan-2-yl)-alkanols and related compounds

Also Published As

Publication number Publication date
FR2529548A1 (fr) 1984-01-06
EP0099789A1 (fr) 1984-02-01
EP0099789B1 (fr) 1987-07-29
ZA834704B (en) 1984-03-28
JPH0587516B2 (es) 1993-12-16
AU1650783A (en) 1984-01-05
FR2529548B1 (es) 1985-04-19
CA1265802A (en) 1990-02-13
DE3372769D1 (en) 1987-09-03
AU562210B2 (en) 1987-06-04
US4657911A (en) 1987-04-14
ES8403897A1 (es) 1984-04-16
JPS5921684A (ja) 1984-02-03

Similar Documents

Publication Publication Date Title
ES524128A0 (es) Procedimiento para la fabricacion de nuevos derivados de la amino-3 quinuclidina
ES529265A0 (es) Procedimiento para la fabricacion de derivados de la piperacina
ES532183A0 (es) Procedimiento para la preparacion de compuestos cefemicos
ES525803A0 (es) Procedimiento para la obtencion de derivados de feniletilamina
ES529774A0 (es) Procedimiento para la produccion de derivados de 1-sulfo-2-oxoacetidina
ES549587A0 (es) Procedimiento para la fabricacion de nuevos derivados nu- cleosidos
ES524997A0 (es) Procedimiento para la preparacion de derivados de la desoxiuridina
ES524978A0 (es) Procedimiento de preparacion de derivados de la quinuclidina
ES527205A0 (es) Procedimiento para la produccion de compuestos poliazoicos
ES526538A0 (es) Procedimiento para la preparacion de nuevas tienobenzodiazepinonas sustituidas
ES528267A0 (es) Procedimiento para la obtencion de nuevos compuestos de aralquiltriazol
ES535185A0 (es) Procedimiento para la preparacion de nuevas oxadiacinas
ES506440A0 (es) Procedimiento para la fabricacion de nuevos compuestos de b-lactama
ES545608A0 (es) Procedimiento para la fabricacion de nuevos compuestos cina-moicos
ES535373A0 (es) Procedimiento para la preparacion de nuevas pirazolil- e isoxazolilsulfonilureas
ES534337A0 (es) Procedimiento para la preparacion de derivados de acridanona
ES525034A0 (es) Procedimiento para la preparacion de derivados de 28-metil-brassinolidas
ES527260A0 (es) Procedimiento para la obtencion de compuestos de 2-heterociclil-tio-alquilo inferior-penem
AR240908A1 (es) Procedimiento para la fabricacion de 2-halogeno- resorcinol
ES523098A0 (es) Procedimiento para la preparacion de compuestos de 4-azaftalida
ES525035A0 (es) Procedimiento para la preparacion de derivados de brassinoesteroides
ES524727A0 (es) Procedimiento para la preparacion de n-acetil-4-triazolidincarboxilato de guayacol
ES500306A0 (es) Procedimiento para la preparacion de nuevos derivados este- roide-espiro-oxatiazolidinos
ES526749A0 (es) Procedimiento para la preparacion de vincamina
AR231530Q (es) Procedimiento para la preparacion de nuevos derivados de la n-3-acil-4-3-amino-2-hidroxi-propoxi-fenil-urea

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040214